Pollmcher & Holsboer, Peptides (1987) Exploration of DSIP's biochemical interactions, receptor targeting, and modulation effects within experimental frameworks
CSPI has argued that move would threaten the publics health because the FDA doesn't review supplements for safety or effectiveness before they hit the market
Both compounds independently cause nausea, vomiting, diarrhea, and constipation - especially during dose increases
Mild redness, swelling, itching, or soreness at the injection site are common and expected
The body answers with nausea and fatigue, the experience turns unpleasant, and they quit convinced the combo does not work for them